Fluid optimisation in pancreas surgery by MATEJ JENKO et al.
       SIGNA VITAE    |    45
Fluid optimisation in pancreas surgery
JENKO MATEJ1, POŽAR-LUKANOVIĆ NEVA1, MLADEN PERIĆ2, SPINDLER-VESEL ALENKA1
1 University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive 'erapy, Zaloška 7, Ljubljana, Slovenia
2 Department of Anesthesiology, Resuscitation and Intensive care, University Hospital Centre Zagreb, • Kišpatićeva ul. 12, Croatia
Corresponding author: 
Alenka Spindler-Vesel
University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive 'erapy, 
Zaloška 7, Ljubljana, Slovenia
alenka.spindler@guest.arnes.si
ABSTRACT
Background. Optimal intravascular blood 
volume, cardiac output and su!cient oxy-
gen supply is a mainstay in major abdomi-
nal surgery. Adequate haemodynamic 
management can improve a favourable 
outcome and shorten the duration of hos-
pital stay.
Our study anticipated di"erent #uid and 
vasoactive drug consumption and less 
complications during the pancreatic sur-
gery in the group of patients where ex-
tended haemodynamic monitoring was 
applied.
Materials and methods. 59 adult patients, 
ASA 2-3, undergoing elective pancreas 
surgery, were included in the study. In 29 
patients in the study group (SG – extended 
haemodynamic monitoring), cardiac in-
dex (CI), mean arterial pressure (MAP) 
and nominal stroke index (SI) were main-
tained within 80% of baseline values with 
actions following study protocol. Patients’ 
groups were homogenous, even when di-
vided into 4 subgroups (control group 
(CG) and without epidural catheter (EC), 
CG and with EC, SG and without EC, SG 
and with EC).
Intraoperative variables (amount of #uids, 
vasopressors, surgery duration) and hospi-
talisation duration, wound healing, reop-
eration, mortality and other complication 
were recorded on the postoperative days 3, 
5, 8, 15 and on hospital discharge.
Results. $ere was no di"erence in ASA 
health status, intraoperative management 
and duration of hospitalisation in 4 sub-
groups. $ere is a signi%cant di"erence in 
intraoperative use of vasopressor support 
between 4 subgroups (Fisher exact test, 
p=0,032). All patients in SG with EC re-
quired vasopressors. Number of patients 
with major complications were not statisti-
cally di"erent between groups. Pulmonary 
embolism, postoperative food intolerance 
and myocardial infarction have occurred 
only in CG. 
Conclusion. In our study there was no dif-
ference in overall #uid and vasoactive drug 
demand. Although in the studied subgroup 
of patients with additional epidural anaes-
thesia there was signi%cantly increased de-
mand for vasoactive drugs. $e incidence 
of complication was low in both groups, 
however, some of major complications oc-
curred only in CG.
Keywords: haemodynamic monitoring, 
+uid optimisation, postoperative outcome, 
pancreatic surgery  
INTRODUCTION
Careful management of oxygen delivery 
by providing adequate intravascular blood 
volume and cardiac output is a mainstay 
in major abdominal surgery. According 
to changes in haemodynamic parameters, 
#uid replacement therapy and vasoactive 
drugs are used (1, 2).
Relative intraoperative hypovolemia could 
result from several factors: drugs used for 
general anaesthesia, the e"ects of local an-
aesthetics if regional anaesthesia is com-
bined with general anaesthesia, systemic 
in#ammatory response to surgical trauma, 
which is proportional to the duration of 
operation and the extent of tissue damage 
(3, 4, 5, 6, 7).
Most patients undergoing pancreatic sur-
gery are elderly and have several comor-
bidities. Adequate haemodynamic man-
agement is of great importance as it can 
improve a favourable outcome and shorten 
the duration of hospital stay (8, 9, 10, 11, 
12, 13).
Our study compared two groups of pa-
tients undergoing elective pancreatic sur-
gery: a control group in which standard 
haemodynamic monitoring was used, and 
a study group in which extended haemo-
dynamic monitoring was applied.
Our study anticipated di"erent #uid and 
vasoactive drug consumption during the 
procedure, less complications due to in-
adequate oxygen delivery in the group of 
patients were extended haemodynamic 
monitoring has been applied.
Our aim was to answer the following ques-
tions:  Does the study group with extended 
haemodynamic monitoring receive signi%-
cantly larger amount of intraoperative #u-
ids and , does it receive signi%cantly more 
vasopressor therapy? As secondary goal, 
we were looking for di"erences in postop-
erative complications. Since epidural anal-
gesia was partly used in the group with ex-
tended haemodynamic monitoring as well 
in the group without it, related haemody-
namic implications with subgroup analysis 
are shown as a tertiary goal.
$e study has been approved by the Na-
tional Medical Ethic Committee of the Re-
public of Slovenia (KME 127/05/12).
MATERIALS AND METHODS
Our study included 59 adult patients un-
dergoing elective pancreas surgery, ASA 
(American society of Anaesthesiologists) 
grade 2-3. 
In the prospective study group (SG) 29 pa-
tients (extended haemodynamic monitor-
ing) were included. Data for control group 
(CG) were obtained from patients’ docu-
mentation. Detailed study protocol is seen 
in Figure 1.
A member of our research team acquired 
an informed consent and provided infor-
mation to all patients on the day prior to 
surgery. Preoperative protocol was the 
same in all our patients.
$e anaesthetic technique did not di"er 
between the two groups.
Upon admission an iv line was inserted, 
patients received midazolam (1-2 mg). A 
thoracic epidural catheter was inserted in 
le& lateral position ($7-8) and a test dose 
of 3 ml of 2 % lidocaine was given. In case 
of contraindications or patient refusal the 
placement of epidural catheter abandoned.
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An arterial line was inserted into radial 
artery. In study group, extended haemody-
namic monitoring of #uid loading, cardiac 
output and changes of peripheral vascular 
resistance by analysing the arterial curve 
was provided by LIDCO Rapid (LiDCO, 
UK).
In both groups unilateral BIS monitor 
(Medtronic, USA) was used to evaluate 
the depth of anaesthesia by means of EEG 
measurement of cortical activity. 
Baseline values of nominal stroke index 
(SI), cardiac index (CI), mean arterial 
pressure (MAP) and regional oxygen satu-
ration (rSO2) were recorded in the study 
group and BIS in both groups.
Upon induction to anaesthesia, all patients 
were given up to 250 ml of crystalloid so-
lutions (antibiotics and other therapy in-
cluded).
Induction of general anaesthesia was con-
ducted with a slow injection of fentanyl 
(3-5 mcg/kg) or sufentanil (0.3-0.5 mcg /
kg), followed by a bolus of propofol (1-2 
mg/kg) or etomidate (0.2 mg/kg) and 
rocuronium (0.6 mg/kg).
Patients were intubated, a nasogastric tube, 
a urine catheter with a temperature probe 
and central venous line were inserted.
Maintenance of general anaesthesia was 
achieved by using inhaled volatile agent 
sevo#urane  in air/oxygen mixture (FiO2 
0.04). Sevo#urane concentration was ti-
trated according to BIS values.
Patients with an epidural catheter received 
a bolus of 15 ml of 0.25 % levobupivacaine 
epidurally, with supplementation of sufen-
tanil 15 g. An epidural block was e!cient 
if no supplemental analgesia was needed 
during operation (analgesia level $1-L2). 
One to two hours a&er an epidural bolus 
of local anaesthetic, a continuous epidural 
infusion was started (0.125% levobupiv-
acaine 200 ml, morphine 4 mg, clonidine 
0.075 mg; infusion rate 5 ml/h, bolus 5 ml, 
lock out time 30 minutes) and continued 
postoperatively as patient-controlled epi-
dural analgesia (PCEA).
In patients without epidural catheter, an 
intravenous infusion of patient-controlled 
analgesia (PCA) with piritramide was 
started at the beginning of laparotomy clo-
sure (infusion rate 1.5-2 mg/h, bolus 1,5-2 
mg, lock out 30 minutes).
Muscle relaxation was monitored and 
rocuronium (10-20 mg) was supplement-
ed according to TOF values. All patients 
received an antiemetic (granisetron 1 mg 
and dexamethasone 8 mg) during opera-
tion. $e depth of anaesthesia was adjust-
ed to maintain BIS values between 40-55. 
Protocol for intraoperative #uid replace-
ment is shown in Figure 2.
At the end of the operation, in both groups 
the muscle block was reversed with suga-
madex (2-4 mg/kg) or neostigmin (2,5 mg) 
and atropine (1 mg), according to TOF val-
ues.
A&er the surgery, patients were transferred 
to postoperative recovery and therea&er to 
Abdominal Surgery's HDU.
In both groups BIS values, the duration of 
operation, blood loss, intraoperative #uid 
and blood supplementation and urine out-
put were recorded.
Hospitalisation duration, readmission to 
HDUs, ICU treatment, wound healing, re-
operation, mortality and other complica-
tions (gut anastomosis dehiscence, sepsis, 
pneumonia, acute respiratory infection, 
pleural e"usion, myocardial infarction, 
lung embolism, cerebrovascular insult, in-
traabdominal infection, urine infection...) 
were recorded on the postoperative days 3, 
5, 8, 15 and on hospital discharge (14).
STATISTICAL ANALYSIS
SPSS statistics program, version 22 (IBM, 
NY, USA) was used to calculate general 
characteristics of included patients and 
intraoperative di"erences among groups. 
Chi square tests and Kruskal - Wallis tests 
were used where appropriate. Results with 
p value < 0,05 were considered statistically 
signi%cant. 
For the graphical interpretation of results 
of 15 days follow up Medplot so&ware was 
used (http://shiny.mf.uni-lj.si/medplot/) 
(15).  For additional statistical analysis of 
major complications, logistic regression 
with the Firth correction was used to es-
timate the association between each of the 
outcome variables (listed in table 6) and 
the selected covariate (use of haemody-
namic monitoring), using the measure-
ments obtained at the selected evaluation 
occasion (15th day a&er surgery).
RESULTS
Patients were randomized in 2 groups, 30 
patients in CG and 29 patients in SG. Gen-
der and ASA health status distribution are 
shown in Table 1 and Table 2. Subgroups 
with epidural were considered separately 
Table 1: Distribution of patients’ gender among test groups.
Group No of included patients Distribution of patients by gender
Female Male
CG, without epidural (1) 7 4 3
CG, with epidural (2) 23 11 12
SG, without epidural (3) 10 4 6
SG, with epidural (4) 19 12 7
Total 59 31 28
CG – control group, SG – study group
Table 2: Distribution of patients according to ASA health status.
Group ASA 1 ASA 2 ASA 3 ASA 4
CG, without epidural (1) 0 3 2 2
CG, with epidural (2) 0 11 12 0
SG, without epidural (3) 0 5 5 0
SG, with epidural (4) 2 7 10 0
Total 2 26 29 2
CG – control group, SG – study group
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Table 3: Characteristics and intraoperative variables of patients included. (Kruskal - Wallis or Mann-Whitney U test were used where ap-
propriate). Group as follows: Control group, without epidural (1), control group with epidural (2), study group, without epidural (3), study 
group with epidural (4). 
Variable group median IQR P value (adjusted)







Standardized Test Statistic: 1,332
Mann-Whitney U test







Standardized Test Statistic: 0,761
Mann-Whitney U test







Standardized Test Statistic: 0,891
Mann-Whitney U test
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Kruskal – Wallis test
Control group, without epidural (1), control group with epidural (2), study group, without epidural (3), study group with epidural (4). 
48   |  SIGNA VITAE
to avoid any bias. However, groups were 
homogenous, even when divided into 4 
subgroups.
Female and male genders were equally dis-
tributed among groups. (Chi-square test, 
p= 0,625).
$ere was equal distribution of patients in 
SG and CG according to their ASA health 
status (Chi square, p=0,243). $ere was no 
di"erence in ASA health status in 4 sub-
groups (Fisher exact test p=0.168)
Personal characteristics and intraoperative 
variables are shown in Table 3. As above, 
patients were also divided into subgroups 
regarding epidural catheter (without epi-
dural and LIDCO monitoring [1], with 
epidural, without LIDCO monitoring [2], 
without epidural, with LIDCO monitoring 
[3], with epidural and LIDCO monitoring 
[4]). No signi%cant di"erences in intraop-
erative management were observed. Dura-
tion of hospitalisation was similar among 
4 subgroups. $ere was no di"erence in 
hospital stay in comparison of SG and CG 
alone (Mann-Whitney U test, p= 0,855).
Intraoperative use of vasopressor support 
was monitored as shown in Table 4. Con-
sidering only SG and CG, the di"erence 
was not signi%cant (Chi square, p=0,08). 
If 4 subgroups were considered (CG and 
without epidural [1], CG and with epi-
dural [2], SG and without epidural [3], 
SG and with epidural [4]), di"erence was 
statistically signi%cant (Fisher exact test, 
p=0,032). All patients in SG with epidural 
required vasopressors.
Postoperative 15 days’ follow-up of some 
of the observed variables is shown in Chart 
1. We have observed some patients with 
Table 4: No. of patients with intraoperative vasopressors. 
Group No. (see text for details) Control group Study group
Without epidural With epidural Without epidural With epidural
Intraoperative vasopressors required















Sum of patients required vasopressors* 23 (76%) 27 (93%)
* Chi square, p=0,08 (no signi%cant di"erence)
Table 5: Number of major complications that have signi,cantly a-ected time and course of patients’ hospitalisation.
Group No major complications 
(No. of patients)
one or more major complications 




List of complications 
CG 25 5 1 1 occurrence of pulmonary embolism, 1 acute 
myocardial infarction, 2 dehiscence of anastomosis, 
2 episodes of delirium
SG 25 4 1 occurrence of ventricular tachycardia, 2 dehiscence 
of anastomosis, 1 episode of delirium
CG – control group
SG – study group
Table 6: Logistic regression with the Firth correction showing the association between the outcome variables and the presence of haemody-
namic monitoring on 15th day a.er surgery.
Variable Odds ratio 95% conf. interval P value
Severe pain (additional therapy 
required)
3.2 0.16 to 476 0.45
RBC transfusion 1 0.0055 to 194 0.99
Foley catheter inserted 0.42 0.071 to 1.9 0.27
Presence of nausea 0.33 0.0022 to 6.5 0.48
Food intolerance 0.33 0.0022 to 6.5 0.48
Rise in creatinine level (>20%) 0.33 0.0022 to 6.5 0.48
Newly ATB therapy 0.24 0.042 to 0.98 0.047*
Oxygen supplementation required 0.13 0.00097 to 1.5 0.11
*statistically signi%cant di"erence 
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multiple complications. Transient rise in 
creatinine levels were observed in 2 pa-
tients in study group and in 1 patient in 
control group. $e renal function of the 
patient in control group returned to pre-
operative level 2 months a&er the hospital 
discharge. Complications that have signi%-
cantly a"ected time and course of patients’ 
hospitalisation are presented in Table 5. 
One patient in control group had 2 major 
complications (acute myocardial infarc-
tion and dehiscence of anastomosis). Some 
complications, that were present 15th day 
from surgery, analysed with logistic re-
gression by their signi%cance are shown in 
Table 6.
DISCUSSION
Fluid optimisation and vasopressors use
$e amount of #uids given during ma-
jor surgery, as pancreas surgery, is unex-
pected. Pearse proved that early #uid op-
timisation during major surgery reduced 
complications, hospital stay and increased 
colloids and vasoactive drugs consump-
tion (8).  In present study there were no 
di"erences in perioperative #uid adminis-
tration, as well as hospital stay.  However, 
detailed subgroup analysis revealed that all 
patients with additional epidural anaesthe-
sia in study group needed more vasoactive 
drugs, which was statistically signi%cant. 
For hip replacement in spinal anaesthesia 
#uid optimised patients received signi%-
cantly more crystalloid #uids and vasoac-
tive drugs (14). Similar observation was 
made for hip replacement in general an-
aesthesia. $e group of patients, that were 
optimised with #uids, received more col-
loids and less crystalloids. Inotropes were 
used more frequently (16).
Postoperative complications and length 
of stay
$e di"erence in observed major com-
plications (acute myocardial infarction, 
dehiscence of anastomosis, pulmonary 
embolism, postoperative delirium, cardiac 
arrhythmia) was not signi%cantly di"er-
ent between groups. However, there were 
two major complications, postoperative 
pulmonary embolism and myocardial in-
farction, both occurred in control group. 
Myocardial damage is otherwise frequent 
in patients a&er major surgery. In high risk 
patients, #uid optimization improved re-
sults in surgical therapy, but it may trigger 
acute myocardial damage (18).
Incidence of gut anastomosis dehiscence 
Figure 1: Study protocol
Figure 2: Intraoperative +uid loss management
Lungs were ventilated with a tidal volume of ≥ 8 ml/kg ideal body weight. Normothermia 
(36- 37°C) and normocapnia (5-5.5kPa) were maintained. 
Chart 1: Results of 15 days follow up are shown (3rd, 5th, 8th and 15th postoperative day). 
'e relative proportion of subjects with positive variable in SG and CG are shown. Created 
with Medplot, http://shiny.mf.uni-lj.si/medplot/.
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is increased if anaemia, blood loss, trans-
fusion and prolonged surgery are present. 
$ere is also in#uence of hypotension, use 
of vasoactive drugs, type of anaesthesia 
and #uid optimisation (17).  In present 
study there was no di"erence in gut anas-
tomosis dehiscence incidence; that could 
be the result of similar perioperative #uid, 
vasoactive drug and transfusion adminis-
tration.
Early mobilisation is important for post-
operative recovery, but is limited with or-
thostatic intolerance, present in 50 % of 
patients in six hours a&er major surgery, 
probably due to hypovolemia besides dys-
regulation of vasomotor tone. Fluid op-
timisation can only improve functional 
hypovolemia. Bundgaard-Nielsen et al. 
report, that #uid optimisation improved 
stroke volume, but could not decrease the 
prevalence for orthostatic intolerance (19). 
It was due to impaired cardiovascular re-
sponse, that prolonged hormonal response 
for mobilisation and hospital stay (19).
Increased need for antibiotics in control 
group 15th day a&er surgery (as can be 
seen in Chart 1) may indicate increased 
risk for postoperative infections. How-
ever, detailed analysis has shown variety 
of reasons for starting therapy, from %rm 
indications such as positive intraoperative 
abdominal swabs to only moderate rise in 
CRP value. 
In already mentioned Cecconi research 
study group of patients had signi%cantly 
fewer minor complications (hypotension, 
anaemia, infections) and less cardiovas-
cular complications (14). Also the study of 
Habicher proved less postoperative bleed-
ing and decreased incidence of morbidity 
(16).
In contrast Phana and co-workers in gut re-
section surgery did not %nd any di"erences 
in incidence of complications and hospital 
stay between optimised and not optimised 
patients (20). Also, Cecconi found no dif-
ference between groups in hospital stay 
(14). On the other hand, Habicher report 
shorter HDU and hospital (16).
Increased mortality and hospital stay could 
be also due to low mean arterial pressure, 
low BIS value and MAC, as was shown by 
Sessler and co-workers (21). In present 
study BIS was maintained between 40 and 
55 and MAP with #uid boluses or vaso-
pressors. $is may be the reason that we 
did not %nd any di"erences in mortality 
and hospital stay in our group of patients.
In prospective, randomized, multicentre 
investigation by Scheeren, individualized 
#uid optimization was studied. More col-
loids administration and less wound in-
fection were observed in #uid optimized 
group of patients. $is #uid protocol based 
on stroke volume variation and stroke 
volume. Probably this approach decreases 
postoperative organ dysfunction (22). 
Overall, the expected decline in morbidity 
was not con%rmed in our study (23,24).
We have not preformed any smaller pre-
study that could serve as simulation for 
power analysis. However, we can discuss 
the e"ect size of results, speci%cally com-
parison of total amount of infused #u-
ids during surgery. $ere is no di"erence 
between study group and control group. 
Estimated r2 based on Standardized Test 
Statistic (Table 3) is 0,02. Related prob-
ability of superiority is 58% (25,26). In 
other words, less than 3% of variability of 
the amount of infused #uids can be inter-
preted because of intraoperative haemo-
dynamic monitoring. Variability among 
patients in our case is much larger than 
e"ect of haemodynamic monitoring and 
only very signi%cantly larger sample might 
show correlation.
$e study has important limitations. A&er 
the surgical procedure, researchers were 
only observers, the attending surgeons 
treated patients. Antimicrobial therapy 
was their decision, based on clinical and 
laboratory %ndings, no special study pro-
tocol was used.
CONCLUSION
In our study there was no di"erence in 
overall #uid and vasoactive drug demand. 
Although in the studied subgroup of pa-
tients with additional epidural anaesthesia 
there was signi%cantly increased demand 
for vasoactive drugs. $e incidence of 
complication was low in both groups and 
with no statistically signi%cant di"erences 
among groups; however, some major com-
plications (pulmonary embolism, acute 
myocardial infarction) occurred only in 
control group.
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